Global Embolotherapy Market Size Study & Forecast, by Disease (Aneurysm, Oncology, Peripheral Vascular), Product (Guidewires, Embolic Agents (Detachable Coils, Microspheres, Pushable Coils)), Procedure, End User (Clinics, Hospitals, Academia, ASC) and Reg

The Global Embolotherapy Market is valued at approximately USD 4.28 billion in 2024 and is anticipated to expand at a CAGR of more than 7.92% during the forecast period of 2025-2035. Embolotherapy has emerged as a critical therapeutic intervention in modern interventional medicine, employed to deliberately occlude abnormal blood vessels for treating complex conditions such as aneurysms, tumors, arteriovenous malformations, and peripheral vascular diseases. This procedure involves introducing embolic agents or devices into the targeted vessel to restrict or stop blood flow, thereby controlling bleeding, shrinking tumors, or preventing aneurysm rupture. The global market expansion is being driven by the rising incidence of chronic diseases, growing adoption of minimally invasive procedures, and the increasing demand for advanced endovascular therapies. Additionally, constant innovations in embolic materials and catheter technologies are enabling physicians to deliver treatment with higher precision and safety, further fueling market growth.

The heightened prevalence of cancer and vascular disorders has intensified the utilization of embolotherapy across healthcare settings. Oncology remains one of the most significant application areas, where embolization is used to cut off the blood supply to tumors, enhancing the effectiveness of chemotherapy or serving as a standalone therapy. According to the World Health Organization, cancer is one of the leading causes of mortality worldwide, accounting for nearly 10 million deaths annually. Likewise, the rising burden of cardiovascular and neurovascular diseases is creating a parallel demand for embolic procedures such as aneurysm coiling and peripheral embolization. Increasing awareness among clinicians and patients regarding the benefits of embolotherapy—such as reduced hospital stay, faster recovery, and minimal post-procedural complications—has also propelled its adoption. However, the market faces certain restraints, including the high procedural cost, limited availability of skilled interventional radiologists, and reimbursement challenges in emerging economies.

Regionally, North America dominated the embolotherapy market in 2025, capturing the largest market share due to its advanced healthcare infrastructure, high patient awareness levels, and significant presence of key industry players. The United States, in particular, continues to lead with robust adoption of minimally invasive procedures and consistent investments in clinical research and product innovation. Meanwhile, Europe has demonstrated steady growth, driven by the growing geriatric population and favorable government support for cancer and cardiovascular treatment programs. The Asia-Pacific region, however, is projected to witness the fastest growth during the forecast period. Rapid industrialization, surging healthcare expenditure, increasing prevalence of cancer in China and India, and rising adoption of interventional radiology techniques are key factors underpinning this expansion. Additionally, public and private investments in strengthening hospital infrastructure and medical device accessibility are further enhancing the region’s market potential.

Major market players included in this report are:
• Medtronic plc
• Boston Scientific Corporation
• Stryker Corporation
• Johnson & Johnson (Cerenovus)
• Penumbra, Inc.
• MicroVention, Inc. (Terumo Corporation)
• Merit Medical Systems, Inc.
• Siemens Healthineers AG
• Cook Medical, LLC
• Balt Extrusion SA
• Abbott Laboratories
• BTG International Ltd. (Boston Scientific)
• Shape Memory Medical Inc.
• Guerbet Group
• Asahi Intecc Co., Ltd.

Global Embolotherapy Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Disease:
• Aneurysm
• Oncology
• Peripheral Vascular

By Product:
• Guidewires
• Embolic Agents (Detachable Coils, Microspheres, Pushable Coils)

By Procedure:
• [Detailed segmentation included in scope]

By End User:
• Clinics
• Hospitals
• Academia
• Ambulatory Surgical Centers (ASC)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more